• Introduction
• Blood Transfusion Demand and Supply
• Synthetic Blood Products
• Summary Market Forecast
• Scope and Methodology

Chapter Two: Introduction: Blood, Associated Disorders, and Blood Products

• Composition, Function and Formation
  
  • Red Blood Cells (Erythrocytes)
  • White Blood Cells (Leukocytes)
  • Platelets
  • Plasma
  
  
• Blood Transfusions
• Synthetic Blood Products: A Suitable Alternative
  • Blood Volume Expanders
  • Hemoglobin Based Oxygen Carriers
  • Perflurocarbon (PFC) Based Blood Products
  • Factor Products for Hemophilia A
  • Synthetic Platelets
  • Synthetic Blood Products Summary

Chapter Three: Novel Synthetic Blood Products in Clinical Trials

• Hemolink (Hemosol)
• Hemopure (Biopure)
• Polyheme (Northfield Laboratories)
• Oxygent (Alliance)
• Oxycyte (Synthetic Blood International)
• PHER-O2 (Sanguine)
• Albrec (Mitsubishi Pharma)
• Advate (Baxter)
• Recombinant Factors
• Synthocytes (Andaris)
• Gene Therapy

Chapter Four: Worldwide Demand and Market Analysis

• Blood Shortage Driving Demand for Alternatives
• Blood Volume Expanders
• Oxygen Carrier Market
• Recombinant Factor Market

Chapter Five: Key Players and Their Technologies

• Alliance Pharmaceuticals Inc.
• Biopure Corp.
• BioTime Inc.
• Hemosol Corp.
• JP Laboratories Inc.
• Northfield Laboratories
• Novo Nordisk A/S
• Perftoran
• Sanguine Corp.
• Synthetic Blood International
• Transkaryotic Therapies Inc.

List of Exhibits

• Exhibit 1: Worldwide Demand for Red Blood Cells by Indication (Acute vs Chronic)
• Exhibit 2: Summary of World Demand for RBCs 2003-2009
• Exhibit 3: Number of High Blood Loss Surgical Procedures by Type
• Exhibit 4: High Blood Loss Market: HBOC and PFC Agents 2007-2013
• Exhibit 5: World Recombinant Factor Market Summary 2003-2009
• Exhibit 6: World Market for Gene Therapy in Blood Disorders 2006-2011
• Exhibit 7: Composition of Blood Plasma
• Exhibit 8: Clinical Uses for Blood Substitutes
• Exhibit 9: HBOCs Sources and Modification by Company
• Exhibit 10: Recombinant Factor Products in Clinical Trials
• Exhibit 11: Average Blood and Component Requirements by Condition
• Exhibit 12: Annual Worldwide Demand for Red Blood Cells
• Exhibit 13: Geographical Distribution of RBC Demand by Region (United States, Europe, Japan, ROW) 2003
• Exhibit 14: Projected World Demand for RBCs 2003-2009
• Exhibit 15: Number of High Blood Loss Surgical Procedures by Type (Number of Procedures, Units of RBCs per Procedure, Total Units Transfused, Market Value) 2003
• Exhibit 16: Blood Volume Expanders Market by Brand 2002-2009
• Exhibit 17: High Blood Loss Market HBOC and PFC Agent Revenues 2007-2013
• Exhibit 18: World Recombinant Factor Market by Brand 2003-2009